Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SCH 58500 |
| Synonyms | |
| Therapy Description |
SCH 58500 is a recombinant adenoviral vector encoding wild-type human TP53 that may introduces TP53 into tumor cells, leading to tumor cell apoptosis (PMID: 12082455). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SCH 58500 | SCH-58500|ACN53 | p53 Gene Therapy 4 | SCH 58500 is a recombinant adenoviral vector encoding wild-type human TP53 that may introduces TP53 into tumor cells, leading to tumor cell apoptosis (PMID: 12082455). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|